Sanofi, Dynavax filing updates on US, German merger compliance moves
MLex Summary: Sanofi and Dynavax Technologies said they will file paperwork with the US antitrust authorities and expect the waiting period for their $2.2. billion deal to expire on Jan. 30....To view the full article, register now.
Already a subscriber? Click here to view full article